Targeting STAT3: A crucial modulator of sepsis

Wangrui Lei1,2, Dianxiao Liu3, Meng Sun4

  • 1Xi'an Key Laboratory of Cardiovascular and Cerebrovascular Diseases, Xi'an No.3 Hospital, School of Life Sciences and Medicine, Northwest University, Xi'an, China.

Insights

Signal transducer and activator of transcription 3 (STAT3) plays a key role in inflammatory responses. Targeting STAT3 shows promise as a therapeutic strategy for sepsis treatment and as a potential biomarker.

Area of Science:

  • Molecular Biology
  • Immunology
  • Critical Care Medicine

Background:

  • Signal transducer and activator of transcription 3 (STAT3) is a crucial transcription factor involved in cellular responses to cytokines and growth factors.
  • STAT3 regulates genes critical for both pro- and anti-inflammatory processes, impacting overall immune homeostasis.
  • Sepsis, a life-threatening condition characterized by dysregulated host response to infection, involves complex inflammatory pathways where STAT3 acts as a central mediator.

Purpose of the Study:

  • To review and evaluate existing literature on the role of STAT3 in experimental and clinical sepsis.
  • To assess the therapeutic potential of targeting STAT3 for sepsis treatment.
  • To explore STAT3's utility as a potential biomarker for sepsis.

Main Methods:

  • Comprehensive literature search of studies investigating STAT3 in sepsis.
  • Analysis of experimental models and clinical data related to STAT3 modulation in sepsis.
  • Synthesis of findings regarding STAT3's involvement in sepsis pathophysiology and treatment.

Main Results:

  • Accumulating evidence highlights STAT3 as a key player in the complex network of inflammatory pathways during sepsis.
  • Studies indicate that modulating STAT3 activity can influence sepsis outcomes in experimental settings.
  • The literature suggests a potential role for STAT3 in both the development and progression of sepsis.

Conclusions:

  • Targeting STAT3 presents a promising therapeutic avenue for managing sepsis.
  • STAT3 holds potential as a valuable biomarker for sepsis diagnosis or prognosis.
  • Further research is warranted to fully elucidate STAT3's role and optimize its therapeutic targeting in sepsis.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.4K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
192
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
14.9K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.1K